Differences in PD-L1 expression on tumor and immune cells between lung metastases and corresponding primary tumors

It has been reported that the tumor microenvironment, including tumor-associated immune cells (ICs) and programmed cell death-ligand 1 (PD-L1) expression, differs between primary and metastatic tumors. This study aimed to elucidate the differences in PD-L1 expression on tumor cells (TCs) and ICs bet...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Surgical oncology 2018-12, Vol.27 (4), p.637-641
Hauptverfasser: Takamori, Shinkichi, Takada, Kazuki, Tagawa, Tetsuzo, Toyokawa, Gouji, Hirai, Fumihiko, Yamashita, Nami, Okamoto, Tatsuro, Oki, Eiji, Yoshizumi, Tomoharu, Oda, Yoshinao, Maehara, Yoshihiko
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:It has been reported that the tumor microenvironment, including tumor-associated immune cells (ICs) and programmed cell death-ligand 1 (PD-L1) expression, differs between primary and metastatic tumors. This study aimed to elucidate the differences in PD-L1 expression on tumor cells (TCs) and ICs between lung metastases and corresponding primary tumors. We analyzed paired lesions from 44 patients diagnosed with lung metastases between 2005 and 2017 at Kyushu University. The percentages of PD-L1-positive TCs and ICs in lung metastases and the primary tumor were classified into five categories (0:
ISSN:0960-7404
1879-3320
DOI:10.1016/j.suronc.2018.08.001